Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection

NCT04363632 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT04363632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04363632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection
Lead sponsor
Centre Leon Berard
Phase
Observational
Overall status
Completed
Start date
April 2, 2020
Completion date
June 30, 2020
Enrollment
1,231 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, sars-cov2